Chenomx Inc. Releases Version 4.6 of Metabolomics Software Suite

Edmonton, Canada (November 6, 2006)

Chenomx Inc. is pleased to announce the release of Chenomx NMR Suite 4.6, reflecting over six years of software and chemistry research and development.

Chenomx NMR Suite is a set of integrated software applications for performing NMR-based metabolomics.  By integrating tools for creating and manipulating metabolic profiles, Chenomx NMR Suite allows users to identify and quantify metabolites in complex NMR spectra with unparalleled speed and accuracy. 

Chenomx NMR Suite can import data acquired with Varian, Bruker or JEOL spectrometers, as well as data from any JCAMP-DX data source.  Chenomx Profiler, part of Chenomx NMR Suite, allows users to rapidly identify and quantify metabolites of interest using Chenomx compound libraries representing over 260 metabolites.  Chenomx Signature Builder, also part of Chenomx NMR Suite, allows users to add their own compounds to a custom compound library, making it easy to identify and quantify any metabolite of interest.

Chenomx NMR Suite 4.6 introduces a new method for combining global and targeted profiling techniques called “residual-based binning.” Residual-based binning captures spectral information that remains after performing targeted profiling of certain compounds. By combining both targeted and global spectral profiling, the user retains the benefits of targeted profiling for known compounds, and gains the extensive spectral coverage of global profiling techniques.  Also new in 4.6 are substantially improved processing features, including novel baseline correction and automatic phasing algorithms.
Adoption of Chenomx NMR Suite in both industrial and academic settings has been swift; Chenomx counts many leading pharmaceutical companies as clients, as well as academic and non-profit institutions from around the world.
Jack Newton, Director of Product Development for Chenomx, adds “With 4.6 we’ve extended the breadth and depth of the tools available to metabolomics researchers.  Residual-based binning is a feature we’re particularly excited about in this release, as it presents the first cohesive method for integrating targeted and global spectral profiling techniques.”

For further information on Chenomx NMR Suite 4.6, please visit www.chenomx.com/products.

About Chenomx, Inc.

Chenomx, Inc. is a privately-held Canadian company that specializes in the development of complex mixture analysis software for broad application in life science technologies. With world-class expertise in NMR spectroscopy, pharmaceutical sciences, and computer software, Chenomx offers a broad range of software products and compound databases to support research efforts in the metabolomics community. Chenomx's flagship product, Chenomx NMR Suite, provides a rich set of tools for identifying and quantifying metabolites in complex NMR spectra. More information on Chenomx and its solutions is available at www.chenomx.com.